Pediatric Nephrology Seminar XXXVII Program

THURSDAY MARCH 11, 2010                                                                                            

5:00-7:00 P.M.        Registration

FRIDAY MARCH 12, 2010

7:00-8:00 A.M.       Registration. Continental Breakfast.

8:00-8:10 A.M.       Introduction. Opening Remarks, Gaston E. Zilleruelo M.D.

SESSION 1: THE NEONATE AND THE KIDNEY

8:10-8:30 A.M.       Development of Kidney Function in the Neonate, Adrian Spitzer M.D.

8:30-8:50 A.M.       Newer Markers in Obstructive Uropathy, Robert Mak M.D., Ph.D.

8:50-9:10 A.M.       The Hypertensive Neonate, Joseph Flynn M.D., M.S.

9:10-9:30 A.M.       Acute Kidney Injury in Critically Ill Newborns: Evaluation, David Askenazi M.D.

9:30-9:50 A.M.       Cystic Kidney Diseases in the Newborn, Lisa Guay-Woodford`M.D.

9:50-10:10 A.M.     Management of the Oliguric Neonate, David Askenazi M.D.

10:10-10:30 A.M.   Panel Discussion

SESSION 2: GENETICS FOR THE CLINICIAN

11:00-11:20 A.M.   Role of Genetic Screening in Renal Diseases, Lisa Guay-Woodford M.D.

11:20-11:40 A.M.   Systems Biology of Glomerular Diseases, Matthias Kretzler M.D.

11:40-12:00 P.M.    Importance of Early Detection of PKD, Lisa Guay-Woodford M.D.

12:00-12:20 P.M.    Genetic Forms of Hypertension, Julie Ingelfinger M.D.

12:20-12:40P.M.     Tubular Channelopathies, Uri S. Alon M.D

12:40-1:00 P.M.      Kidney Involvement in Genetic Syndromes, Paul Benke M.D., PhD

1:00-1:30 P.M.        Panel Discussion

1:30-2:30 P.M.        Meet the Professor Lunch

SESSION 3: WORKSHOP ON RENAL-GU ANOMALIES

3:00-5:00 P.M.

                                Antenatal Hydronephrosis: When to Intervene? Ruben Quintero M.D.

                                Renal Scintigraphy in the Evaluation of the Obstructed Kidney, George N. Sfakianakis M.D.

                                Newer Imaging Techniques in Obstructive Uropathy, Andrew J. Kirsch

                                Proteinuria as a Marker of Severe Obstruction  Carolyn Abitbol M.D.

                                A Neonate With Severe UPJO: To Operate or Not ?

                                Andrew J. Kirsch M.D. Rafael Gosalbez M.D.      

5:00-5:30 P.M.        Special Presentation: Why the Kidneys Fail? H. William Schnaper  M.D.

5:30-7:30 P.M.        WELCOME RECEPTION

SATURDAY MARCH 13, 2010

7.30-8:00 A.M.       Registration. Continental Breakfast.

SESSION 4: RENIN ANGIOTENSIN SYSTEM (RAS) AND THE KIDNEY

8:00-8:20 A.M.       Development of  RAS in early life, Ariel R. Gomez M.D.

8:20-8:40 A.M.       The role of RAS in salt-sensitive hypertension, Bernardo Rodriguez-Iturbe M.D.

8:40-9:00 A.M.       RAS and the Podocyte, Jochen Reiser M.D.

9:00-9:20A.M.        Aldosterone and CKD, Murray Epstein M.D.

9:20-9:40 A.M.       RAS Blockade in Children, Guido Filler M.D.

9:40-10:00 A.M.     Renin/Aldosterone Inhibition in Children, Joseph Flynn M.D.

10:00-10:30 A.M.   Panel Discussion

10:30-11:00 A.M.   Break and Visit Exhibits

SESSION 5: CHRONIC KIDNEY DISEASE

11:00-11:20 A.M.   NAPRTCS/CKids Registries: What Have We Learned So Far? Frederick J. Kaskel M.D., Ph.D.

11:20-11:40 A.M.   CKD Registries in Latin America, Nelson Orta M.D.

11:40-12:00 P.M.    Health Disparities in Pediatric Kidney Disease, Marva Moxey-Mims M.D.

12:00-12:20 P.M.    Hypertension in CKD: Are We Doing a Good Job?, Mark Mitsnefes M.D.                          

12:20-12:40 P.M.    Role of rHu-GH in CKD, Dialysis and Transplant, Richard N. Fine M.D.

12:40-1:00 P.M.      Challenges in Renal Transplant: How Can We Improve Outcomes?, Guido Filler M.D.                            

1:00-1:30 P.M.        Panel Discussion

1:30-2:30 P.M.        Meet the Professor Lunch

SESSION 6: WORKSHOP ON METABOLIC BONE DISEASE

3:00-5:30 P.M.

                                 iPTH: Which Is the Target?   Isidro Salusky M.D.

                                 P or FGF23: Which is More Important? Myles Wolf  M.D.

                                 VDR Activators and Bone Protection. Michael Freundlich M.D.

                                Vascular Calcifications in Pediatric CKD Isidro Salusky M.D.

                                Vitamin D Insufficiency in Dialysis W. Seeherunvong M.D.

                                Metabolic Bone Disease: What’s New?  Jose Weisinger M.D.                  

5:30-6:00 P.M. Special Presentation: Transplantation in Children: Update 2010, Richard N. Fine M.D.

SUNDAY MARCH 14, 2010

7:00-8:00 A.M.       Registration. Continental Breakfast.

SESSION 7: RESEARCH AND TRAINING INITIATIVES

8:00-8:20 A.M.       Research Training and NIH Initiatives  Marva Moxey-Mims M.D.

8:20-8:40 A.M.       Career Development in Pediatric Nephrology William Smoyer M.D.

8:40-9:00 A.M.       Ethical Issues in Manuscript Writing and Publication  Julie R. Ingelfinger M.D.

SESSION 8: WORKSHOP ON CLINICO-PATHOLOGIC CORRELATIONS

9:00-9:30 A.M.       FSGS: A Pathologist Perspective  Helmut G. Rennke M.D

9:30-10:30 A.M.     Biopsy Discussions: Rafael Valenzuela M.D., Jayanthi Chandar M.D.

A case of refractory SLE, congenital NS, FSGS, HIVAN. Maria M. Rodriguez M.D.

10:30-11:00 A.M.   Break. Visit Exhibit.

SESSION 9: THE KIDNEY IN SYSTEMIC DISEASES

11:00-11:20 A.M.   Obesity and the Kidney Robert Mak M.D.

11:20-11:40 A.M.   Diabetic Nephropathy: When to Diagnose and How to Intervene, Michael Mauer, M.D. 

11:40-12:00 A.M.   HIVAN: An Update, Patricio Ray M.D.

12:00-12:20 P.M.    Systemic Lupus Erythematosus: B Cell Depletion, Carolyn Abitbol M.D.

12:20-12:40 P.M.    Role of Lipids in Kidney Disease, Mark Mitsnefe M.D.

12:40-1:00 P.M.      KDIGO Guidelines on Hepatitis C in CKD, David Roth M.D.

1:00-1:30 P.M.        Panel Discussion

ADJOURN